In a six-month study, people taking the 14 mg daily dose lost around 4% of their body weight
No room-temperature stability data for retatrutide are publicly available, and no allowance should be assumed
In this study, there was a significant change in TEs
A failure to obtain accelerated approval or any other form of expedited development, review or approval for our product candidate would result in a longer time period to commercialization of such product candidate, could increase the cost of development of such product candidate and could harm our competitive position in the marketplace
In patients with T2D, model outcome was mostly affected by eGFR followed by age and the serum concentrations of the uremic toxin p -cresol 30 and D -threitol, also indicative of kidney function 39
38 Araki O, Ying H, Zhu XG, Willingham MC, Cheng SY